Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Jayne Hamilton has her feet on the ground, knows the rules of dating in a modern world and has to admit that there is NO dating guide ever written that mentions what a girl should do when Lucifer turns out to be a Total Angel and the man of your dreams. Except hang on! H.E.LLc is working with Heaven Inc. and this merger is HELLarious! Find out more at http://www.TheEternityGambit.com or http://www.ReneeBernardAuthor.com Romance/paranormal/comedy
TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials.
One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
Blu® Homes, Inc. (“Blu”), America’s leading provider of premium prefab homes, today announced an elegant new home model. The spacious and luxurious 2014 Element offers architect-designed styling featuring sweeping, high ceilings, and a glorious indoor/outdoor living style sparked by walls of windows and glass doors.
The Element also boasts well designed storage space, a spacious open floor plan with seamlessly connected living, dining and kitchen spaces and a cook’s kitchen highlighted by generous counter space, luxury appliance upgrade options, and beautiful use of natural light.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/70432511-blu-homes-releases-updated-element-design
To motivate parents and their children to spend more time in nature together, the U.S. Forest Service and the Ad Council today launched a new public service advertisement (PSA) campaign urging families to experience the many wonders of nature close to home together.
The PSAs, created in partnership with The Foundry, Time Inc.’s state-of-the-art creative lab and content studio, focus on family time in nearby forested environments, reminding parents that having a nature experience with their children is not only easy and local, but also fun and full of learning opportunities and benefits. This is the first time that the Ad Council has worked with the creative division of a media company that has iconic roots in publishing on a large-scale production on behalf of one of its PSA campaigns. A range of Time Inc. properties are also donating print and digital advertising space in support of this campaign.
To view the multimedia release go to:
https://www.multivu.com/players/English/8171051-new-ad-council-u-s-forest-services-discover-the-forest-psa/
The International Nut and Dried Fruit Council (INC) has celebrated the XXXV World Nut and Dried Fruit Congress in San Diego. From May 30th until today, more than 1,400 delegates have participated in the only and largest international event dedicated to the nut and dried fruit industry that this year’s edition has broken previous records of attendance.
The INC Congress featured a stimulating three-day program to exchange knowledge, ideas and experiences. Attendees had over 16 sessions, among round tables, seminars and keynote speakers’ presentations ranging in topics from market dynamics, crops and production forecasts, agricultural and water resources, new findings in health and nutrition, and product innovations.
Steve Junqueiro, Co-president and COO of Save Mart Supermarkets, shared his vision on the future of American supermarkets. He outlined a market featured by a more digital consumer driven by food transparency, convenience, connectivity, emotional connection and local and sustainable supply.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7849351-inc-world-nut-dried-fruit-congress/
Eisai Inc. today announced the launch of a new national television advertising campaign for BELVIQ® (lorcaserin HCl) CIV, an FDA-approved prescription therapy for chronic weight management. The advertisement will air on numerous channels including Lifetime, Oxygen and AMC.
The spot illustrates the struggles many people face when they are trying to lose or control their weight. BELVIQ is presented as a targeted approach to weight loss, that, when combined with diet and increased activity, may help some patients lose weight and keep it off.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7161051-eisai-launches-national-television-campaign-belviq-lorcaserin-hcl-civ
Free The Children, an international charity and educational partner that focuses on delivering aid to impoverished children around the world, announced it has standardized on DocuSign, Inc. (DocuSign®) for Digital Transaction Management (DTM). With DocuSign, Free The Children keeps administrative spending to a minimum so it can ensure at least $0.90 of every dollar donated goes to supporting programs that directly benefit children in need around the world.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7312252-docusign-free-the-children-digital-transaction-management/
The Light of Life Foundation, ThyCa: Thyroid Cancer Survivors’ Association, Inc., and Eisai Inc. today announced the launch of Myths and Truths About Thyroid Cancer, an interactive, educational campaign designed to help dispel the myth that thyroid cancer is a “good cancer.” Because most thyroid cancers can be successfully treated, many are told if you are going to get cancer, thyroid cancer is the one to have, which has led to this misperception. However, whether successfully treated or not, the truth is all cancers can have a significant impact on a person’s life, beginning with the shock and distress of hearing the word “cancer” at diagnosis. In honor of Thyroid Cancer Awareness Month and the tens of thousands who receive a thyroid cancer diagnosis each year, Myths and Truths About Thyroid Cancer illustrates the life-changing realities of this disease.
“As a thyroid cancer survivor, I urge people to stop referring to thyroid cancer as the ‘good cancer,’ as I believe it downplays patients’ experiences,” said Joan Shey, founder of the Light of Life Foundation. “I hear time and time again from patients how difficult their diagnosis and treatment were and that their scars are more than skin deep. My hope is that this campaign can educate about the many types of thyroid cancer and change the thyroid cancer conversation.”
“Being part of a community of survivors is very important for people coping with thyroid cancer,” said Gary Bloom, thyroid cancer survivor and co-founder and executive director of ThyCa: Thyroid Cancer Survivors’ Association. “ThyCa takes this to heart, which is why we are proud to provide support and resources to the thyroid cancer community. We also know more needs to be done to elevate awareness of thyroid cancer and what patients need in terms of support for the rest of our lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7595951-eisai-thyroid-cancer-myths/
Quadriplegic former IndyCar driver and current team owner Sam Schmidt completed the bottom half of the challenging, high-altitude Broadmoor Pikes Peak International Hill Climb yesterday in the Arrow Electronics, Inc. (NYSE:ARW) Semi-Autonomous Motorcar (SAM car).
Schmidt, who was paralyzed from the neck down in a crash during an IndyCar practice lap in 2000, is able to steer, accelerate and brake the modified 2016 Corvette Z06 SAM car using only his head. Sensors mounted on an Arrow-designed high-tech headset that Schmidt wears connect to infrared cameras mounted on the dashboard and detect his head-tilt motions to steer. A sip-and-puff device that Smith breathes into enables him to accelerate and brake.
http://www.avalanwireless.com
AvaLAN Wireless - A business organization dealing in all types of wireless networking products namely wireless extender, wireless dome housing, access point radio, camera housings, 900 mhz wireless, rf modules, wireless spectrum analyzers etc.
Equinix, Inc. (Nasdaq: EQIX), the global interconnection and data center company, today announced that its Board of Directors has appointed Charles Meyers to the position of President and Chief Executive Officer, effective immediately. Meyers will also join Equinix’s Board of Directors. He succeeds Peter Van Camp, who has served as interim CEO since January 2018. Van Camp will resume his role as Executive Chairman of the Equinix Board of Directors.
To view the multimedia release go to:
https://www.multivu.com/players/English/8059152-equinix-charles-meyers-president-ceo/
